Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Angle Share News (AGL)
AGL Share
Price
AGL Share
News
AGL Share
Chat
AGL Share
Trades37
AGL
Live RNS
AGL Share
Charts
AGL Broker
Ratings
AGL Directors
Deals
AGL Financial
Diary
AGL
Fundamentals
AGL Short
Positions
AGL
Media
AGL Company
Research
AGL Company
Timeline
- There is currently no data for AGL
IN BRIEF: Angle highlights supportive data for DNA analysis tool
Angle PLC - Surrey-based medical diagnostics provider - Announces publication of a peer-reviewed paper in a special issue of the journal - "Current Issues in Molecular Biology" Special Issue: Advanced Solutions for Cancer Therapy. Article brings together supporting evidence for the additional and complementary information that can be obtained from circulating tumour cells, demonstrating the value of a dual analyte approach for both CTCs and ctDNA (fragments of DNA released mainly by dying cells). Angle recently announced breakthrough data for real-time parallel next generation sequencing DNA analysis of both ctDNA and CTCs from a single tube of patient blood, using a pan-cancer panel run on an Illumina NGS system.
Current stock price: 17.85 pence, down 8.5% in London on Monday
12-month change: down 42%
By Jeremy Cutler, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2024 Alliance News Ltd. All Rights Reserved.
Latest AGL News
- IN BRIEF: Angle notes studies supporting Parsortix system in cancer
27 Sep 2021 - UK earnings, trading statements calendar - next 7 days
23 Sep 2021 - IN BRIEF: Angle's Parsortix used in Spanish study to find cancer
22 Sep 2021 - IN BRIEF: Angle's Parsortix enables gene analysis in cancer study
21 Sep 2021 - TRADING UPDATES: Netcall wins new deal; Sareum raises GBP1 million
9 Aug 2021 - TRADING UPDATES: United Oil & Gas in North Sea sale; Trifast confident
28 Jul 2021 - Angle agrees pharma services contract with new customer
28 Jul 2021 - IN BRIEF: Angle's Parsortix successfully used to harvest cancer cells
9 Jul 2021
Related News
IN BRIEF: Angle names Peter Collins as interim CEO
(Alliance News) - Angle PLC - Guildford, England-based liquid biopsy company, which is to be renamed CelLBxHealth PLC - Appoints Peter Collins as inte...
Angle touts planned name and strategy change, Groen turns executive
(Alliance News) - Angle PLC shares fell on Wednesday, after it announced plans to rename itself CelLBxHealth PLC and "[pursue] a revised strategy", wi...
IN BRIEF: Angle CEO and finance lead step down after shareholder talks
Angle PLC - Guildford, England-based liquid biopsy company - Says that, following talks with an unnamed "significant shareholder", Chief Executive Off...
Angle News
IN BRIEF: Angle notes studies supporting Parsortix system in cancer
IN BRIEF: Angle notes studies supporting Parsortix system in cancer
UK earnings, trading statements calendar - next 7 days
UK earnings, trading statements calendar - next 7 days
IN BRIEF: Angle's Parsortix used in Spanish study to find cancer
IN BRIEF: Angle's Parsortix used in Spanish study to find cancer
IN BRIEF: Angle's Parsortix enables gene analysis in cancer study
IN BRIEF: Angle's Parsortix enables gene analysis in cancer study
TRADING UPDATES: Netcall wins new deal; Sareum raises GBP1 million
TRADING UPDATES: Netcall wins new deal; Sareum raises GBP1 million
TRADING UPDATES: United Oil & Gas in North Sea sale; Trifast confident
TRADING UPDATES: United Oil & Gas in North Sea sale; Trifast confident
Angle agrees pharma services contract with new customer
(Sharecast News) - Liquid biopsy company Angle has agreed a pharma services contract with another new customer, it announced on Wednesday, for its rec...
IN BRIEF: Angle's Parsortix successfully used to harvest cancer cells
IN BRIEF: Angle's Parsortix successfully used to harvest cancer cells
Follow the stocks
